- Q2 2024 Medivir AB Earnings Call Transcript5 days agokr2.93Earnings
- Q4 2023 Medivir AB Earnings Call TranscriptFeb 15, 2024kr3.57Earnings
- Medivir AB to Discuss the Updated Data in Advanced Hepatocellular Carcinoma Call TranscriptJan 23, 2024
- Q3 2023 Medivir AB Earnings Call TranscriptOct 27, 2023kr7.35 (+5.00%)Earnings
- Q2 2023 Medivir AB Earnings Call TranscriptAug 18, 2023kr7Earnings
- Q1 2023 Medivir AB Earnings Call TranscriptApr 27, 2023kr7.92Earnings
- Q4 2022 Medivir AB Earnings Call TranscriptFeb 15, 2023kr7.92Earnings
- Medivir AB at Redeye Fight Cancer Day (Virtual) TranscriptJan 19, 2023
- Q3 2022 Medivir AB Earnings Call TranscriptNov 03, 2022kr7.92Earnings
- Q2 2022 Medivir AB Earnings Call TranscriptAug 19, 2022kr8.05Earnings
- Q1 2022 Medivir AB Earnings Call TranscriptApr 28, 2022kr8.05Earnings
- Q4 2021 Medivir AB Earnings Call TranscriptFeb 15, 2022kr8.35Earnings
- Q3 2021 Medivir AB Earnings Call TranscriptNov 03, 2021kr9.99Earnings
- Medivir AB to Discuss Update on the Progress and Plans for the MIV-818 Program Call TranscriptSep 16, 2021
- Q2 2021 Medivir AB Earnings Call TranscriptAug 19, 2021kr10.56 (-5.55%)Earnings
- Q1 2021 Medivir AB Earnings Call TranscriptApr 28, 2021kr7.88Earnings
- Q4 2020 Medivir AB Earnings Call TranscriptFeb 26, 2021kr8.66Earnings
- Medivir AB to Discuss Exclusive Licensing Agreement with IGM Biosciences for Birinapant Call TranscriptJan 12, 2021
- Q3 2020 Medivir AB Earnings Call TranscriptNov 10, 2020kr14.06Earnings
- Q2 2020 Medivir AB Earnings Call TranscriptAug 20, 2020kr16.6Earnings
- Q1 2020 Medivir AB Earnings Call TranscriptMay 05, 2020kr11.44Earnings
- Medivir AB R&D Day TranscriptMar 02, 2020
- Q4 2019 Medivir AB Earnings Call TranscriptFeb 13, 2020kr14.56Earnings
- Q3 2019 Medivir AB Earnings Call TranscriptNov 27, 2019kr21.55Earnings
- Q2 2019 Medivir AB Earnings Call TranscriptAug 28, 2019kr24.68Earnings
- Medivir AB to Discuss the Development of Phase IA Study with MIV-818 Call TranscriptJun 13, 2019
- Q1 2019 Medivir AB Earnings Call TranscriptMay 03, 2019kr19.08Earnings
Q2 2023 Medivir AB Earnings Call Transcript
Welcome to the Medivir Q2 report 2023. (Operator Instructions) Now, I will hand the conference over to CEO, Jens Lindberg. Please go ahead.
Thank you, and welcome, everyone, logging in or dialing in to this webcast, a Friday afternoon webcast, not usually the day we run this. But hopefully, we can close out the week with a good session. We have had quite an eventful quarter at Medivir, and we are at a very exciting time for the company and for our lead program, fostrox, in liver cancer. And we very much look forward to sharing more details in the webcast today as we move forward.
So we were planning to be four today; we will be three. We are missing our CMO, Pia, today. She has actually come down with cold and a fever. And most importantly, she has lost her voice. So you are going to have to make do with us today. And unfortunately, that means you will need to hear a lot from me during the session today.
Important information, I will not go through it in detail. We'll be -- you will find our presentation on the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)